<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pharmateca</journal-id><journal-title-group><journal-title xml:lang="en">Pharmateca</journal-title><trans-title-group xml:lang="ru"><trans-title>Фарматека</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2073-4034</issn><issn publication-format="electronic">2414-9128</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">294514</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Status of oropharyngeal and colonic microbiota, and phagocytic activity of peripheral blood neutrophiles in children with Mycoplasma pneumoniae infection</article-title><trans-title-group xml:lang="ru"><trans-title>Состояние микробиоты ротоглотки и толстого кишечника, фагоцитарной активности нейтрофилов периферической крови у детей с инфекцией Mycoplasma pneumoniae</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Meskina</surname><given-names>E. R</given-names></name><name xml:lang="ru"><surname>Мескина</surname><given-names>Е. Р</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khadisova</surname><given-names>M. K</given-names></name><name xml:lang="ru"><surname>Хадисова</surname><given-names>М. К</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD, Researcher at the Department of Children’s Infectious Diseases</p></bio><bio xml:lang="ru"><p>к.м.н., науч. сотр. детского инфекционного отделения</p></bio><email>murzabekova.marina.1979@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rusanova</surname><given-names>E. V</given-names></name><name xml:lang="ru"><surname>Русанова</surname><given-names>Е. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">SBHCI MR Moscow Regional Scientific Research Clinical Institute n.a. M.F. Vladimirsky</institution></aff><aff><institution xml:lang="ru">ГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2018</year></pub-date><volume>25</volume><issue>1</issue><issue-title xml:lang="en">NO1 (2018)</issue-title><issue-title xml:lang="ru">№1 (2018)</issue-title><fpage>69</fpage><lpage>75</lpage><history><date date-type="received" iso-8601-date="2023-02-27"><day>27</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, ООО «Бионика Медиа»</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/2073-4034/article/view/294514">https://journals.eco-vector.com/2073-4034/article/view/294514</self-uri><abstract xml:lang="en"><p>Infection caused by Mycoplasma pneumoniae is a significant public health problem due to the high prevalence, increasing incidence, a significant etiological role in the development of community-acquired pneumonia. The article presents the results of the evaluation of the status of the oropharyngeal and colonic microbiota and the phagocytic activity of peripheral blood neutrophils in 91 children aged 1 to 7 years who were admitted to a hospital with acute upper and lower respiratory tract infections. Mycoplasma infection (MI) was diagnosed in 35.3% of the examined children, incl. community-acquired pneumonia - in 8,8%. Patients with MI were diagnosed with a severe dysbiosis on the mucous membranes of the oropharynx and intestine, whose markers were a deficiency in growth of Neisseria and Escherichia, respectively, and high isolation rates of Gram-negative enterobacteria, Pseudomonas aeruginosa and Candida fungi (50% and 100%, respectively). In patients with MI (in comparison with acute respiratory diseases of other etiology), deeper violations of the lysing function of peripheral blood phagocytic neutrophils and incomplete phagocytosis, more pronounced in pneumonia, were revealed.</p></abstract><trans-abstract xml:lang="ru"><p>Инфекция, вызванная Mycoplasma pneumoniae, - весомая проблема здравоохранения в связи с широкой распространенностью, ростом заболеваемости, весомой этиологической ролью в развитии внебольничной пневмонии. Представлены результаты исследования состояния микробиоты ротоглотки и толстого кишечника, фагоцитарной активности нейтрофилов периферической крови у 91 ребенка в возрасте от 1 года до 7 лет, госпитализированного в стационар с острыми инфекциями верхних и нижних дыхательных путей. Микоплазменная инфекция (МИ) была диагностирована у 35,3% обследованных детей, в т.ч. внебольничная пневмония у 8,8%. У пациентов с МИ диагностирован более глубокий дисбиоз на слизистых оболочках ротоглотки и кишечника, маркерами которого были дефицит роста нейссерий и эшерихий соответственно и высев грамотрицательных энтеробактерий, Pseudomonas aeruginosa и грибов рода Candida (50 и 100% соответственно). У пациентов с МИ (по сравнению с острыми респираторными заболеваниями другой этиологии) выявлены более глубокие нарушения лизирующей функции фагоцитирующих нейтрофилов периферической крови и незавершенный фагоцитоз, более выраженные при пневмонии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Mycoplasma pneumoniae</kwd><kwd>acute respiratory diseases</kwd><kwd>Mycoplasma pneumoniae</kwd><kwd>oropharyngeal microbiota</kwd><kwd>fecal microflora</kwd><kwd>phagocytosis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>острые респираторные заболевания</kwd><kwd>микробиота ротоглотки</kwd><kwd>фекальная микрофлора</kwd><kwd>фагоцитоз</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Самсыгина Г.А. Микоплазмоз респираторного тракта у детей и подростков. Consillium Medicum. Приложение. Педиатрия. 2011; 4: 67-70.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Marchello C., Dale A.P., Thai T.N., Han D.S., Ebell M.H. Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis. Ann. Fam. Med. 2016; 14(6): 552-66.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Yamazaki T., Kenri T. Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae. Front. Microbiol. 2016; 7: 693.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Sun H., Xue G., Yan C., Li S., Zhao H., Feng Y., Wang L. Changes in Molecular Characteristics of Mycoplasma pneumoniae in Clinical Specimens from Children in Beijing between 2003 and 2015. PLoS One. 2017; 12(1): e0170253.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Tian D.D., Jiang R., Chen X.J., Ye Q. Meteorological factors on the incidence of MP and RSV pneumonia in children. PLoS One. 2017; 12(3): e0173409. Doi: 10.1371/journal.pone.0173409. eCollection 2017.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Liao J.Y., Zhang T. Distribution characteristics of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in hospitalized children with acute respiratory tract infection: an analysis of 13 198 cases. Zhongguo Dang Dai Er Ke Za Zhi. 2016; 18(7): 607-13.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Jain S., Williams D.J., Arnold S.R., Ampofo K., Bramley A.M., Reed C., Stockmann C., Anderson E.J., Grijalva C.G., Self W.H., Zhu Y., Patel A., Hymas W., Chappell J.D., Kaufman R.A., Kan J.H., Dansie D., Lenny N., Hillyard D.R., Haynes L.M., Levine M., Lindstrom S., Winchell J.M., Katz J.M., Erdman D., Schneider E., Hicks L.A., Wunderink R.G., Edwards K.M., Pavia A.T., McCullers J.A., Finelli L; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. children. N. Engl. J. Med. 2015; 372(9): 835-45.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J. Infect. Chemother. 2010; 16: 162-69.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Izumikawa K. Clinical Features of Severe or Fatal Mycoplasma pneumoniae Pneumonia. Front Microbiol. 2016; 7: 800.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Spuesens E.B., Fraaij PL., Visser E.G., Hoogenboezem T., Hop W.C., van Adrichem L.N., Weber F., Moll H.A., Broekman B., Berger M.Y., van Rijsoort-Vos T., van Belkum A., Schutten M., Pas S.D., Osterhaus A.D., Hartwig N.G., Vink C., van Rossum A.M. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013; 10(5): e1001444.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Nilsson A.C., Bjorkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC. Microbiol. 2008; 8: 93.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Saraya T., Nakata K., Nakagaki K., MotoiN., Iihara K., Fujioka Y., Oka T., Kurai D., Wada H., Ishii H., Taguchi H., Kamiya S., Goto H. Identification of a mechanism for lung inflammation caused by Mycoplasma pneumoniae using a novel mouse model. Results Immunol. 2011; 1(1): 76-87.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Chaudhry R., Ghosh A., Chandolia A. Pathogenesis of Mycoplasma pneumoniae: An update. Indian. J. Med. Microbiol. 2016; 34(1): 7-16.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Techasaensiri C, Tagliabue C.,Cagle M.,Iranpour P, Katz K., Kannan T.R., Coalson J.J., Baseman J.B., Hardy R.D. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains. Am. J. Respir. Crit. Care Med. 2010; 182(6): 797-804.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Jiang W., Yan Y., Ji W., Wang Y., Chen Z. Clinical significance of different bacterial load of Mycoplasma pneumoniae in patients with Mycoplasma pneumoniae pneumonia. Braz. J. Infect. Dis. 2014; 18: 124-28.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>de Steenhuijsen Piters W.A., Sanders E.A., Bogaert D. The role of the local microbial ecosystem in respiratory health and disease. Philos. Trans R Soc. bond B Biol. Sci. 2015; 19; 370(1675).</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Marsland B.J., Trompette A., Gollwitzer E.S. The Gut-Lung Axis in Respiratory Disease Ann. Am. Thorac. Soc. 201512(Suppl. 2): 150-56.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Wang H., Dai W., Qiu C., Li S., Wang W., Xu J., Li Z., Wang H., Li Y., Yang Z., Feng X., Zhou Q., Han L., Li Y., Zheng Y. Mycoplasma pneumoniae and Streptococcus pneumoniae caused different microbial structure and correlation network in lung microbiota. J. Thorac. Dis. 2016; 8(6): 1316-22.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Rosas-Salazar C., Shilts M.H., Tovchigrechko A., Schobel S., Chappell J.D., Larkin E.K., Shankar J., Yooseph S., Nelson K.E., Halpin R.A., Moore M.L., Anderson L.J., Peebles R.S., Das S.R., Hartert T.V. Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in Infancy. J. Infect. Dis. 2016; 214(12): 1924-28.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Внебольничная пневмония у детей. Клинические рекомендации. Российское респираторное общество. Межрегиональное педиатрическое респираторное общество. Федерация педиатров стран СНГ. Московское общество детских врачей. М., 2015. 64 с.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Эпштейн-Литвак Р.В. Бактериологическая диагностика дисбактериоза. Методические рекомендации. М., 1977: 20.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Воропаева Е.А. Микробная экология и гистаминобразующая активность микроорганизмов задней стенки глотки детей, больных бронхиальной астмой. Дисс.. канд. мед. наук. М., 2002.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Лебедев К.А., Понякина И.Д. Иммунограмма в клинической практике. М., 1990. 223 с.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Феклисова Л.В., Мескина Е.Р., Галкина Л.А., Целипанова Е.Е., Савицкая Н.А., Воропаева Е.А. Современные подходы к коррекции микробиоценоза ротоглотки. Леч. врач. 2009; 10: 1-3.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Biesbroek G., Tsivtsivadze E., Sanders E.A., Montijn R., Veenhoven R.H., Keijser B.J., Bogaert D. Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children. Am. J. Respir. Crit. Care Med. 2014; 190: 1283-12.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Pettigrew M.M., Gent J.F., Kong Y., Wade M., Gansebom S., Bramley A.M., Jain S., Arnold S.L., McCullers J.A. Association of sputum microbiota profiles with severity of community-acquired pneumonia in children. BMC. Infect. Dis. 2016; 16: 317.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Lee W.J., Huang E.Y., Tsai C.M., Kuo K.C., Huang Y.C., Hsieh K.S., Niu C.K., Yu H.R. Role of Serum Mycoplasma pneumoniae IgA, IgM, and IgG in the Diagnosis of Mycoplasma pneumoniae-Related Pneumonia in School-Age Children and Adolescents. Clin. Vaccine Immunol. 2017; 24(1): e00471-16.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Королева Е.Г., Осидак Л.В., Милькинт К.К., Головачева Е.Г., Румель Н.Б., Орлов А.В., Потапенко Л.Б. Респираторная микоплазменная инфекция у детей с отягощенным преморбидным фоном. Дет. инфекции. 2004: 4: 17-22.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Широбоков В.П. Медицинская микробиология, вирусология и иммунология. Винница, 2015. 898 с.</mixed-citation></ref></ref-list></back></article>
